The association of maternal thyroid function with placental hemodynamics

Human Reproduction

Volumn 32, Issue 3, 2017, Pages 653-661

  Barjaktarovic, M ^a   Korevaar, T I M ^a   Chaker, L ^a   Jaddoe, V W V ^a,b   De Rijke, Y B ^a,b   Visser, T J ^a   Steegers, E A P ^b   Peeters, R P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Placenta; Placental hemodynamics; Pregnancy; Thyroid function

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTERY RESISTANCE; ARTICLE; BIRTH WEIGHT; DOPPLER FLOWMETRY; FEMALE; FIRST TRIMESTER PREGNANCY; FREE THYROXINE INDEX; GESTATIONAL AGE; HEMODYNAMICS; HUMAN; MATERNAL SERUM; PLACENTA CIRCULATION; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PROSPECTIVE STUDY; PULSATILITY INDEX; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UMBILICAL ARTERY; UMBILICAL ARTERY PULSATILITY INDEX; UTERINE ARTERY; UTERINE ARTERY RESISTANCE INDEX; BLOOD; DIAGNOSTIC IMAGING; DOPPLER ULTRASONOGRAPHY; PHYSIOLOGY; PLACENTA; PREGNANCY; THYROID GLAND; VASCULAR RESISTANCE; VASCULARIZATION; YOUNG ADULT;

ADULT; FEMALE; HEMODYNAMICS; HUMANS; PLACENTA; PREGNANCY; THYROID GLAND; THYROTROPIN; THYROXINE; ULTRASONOGRAPHY, DOPPLER; UMBILICAL ARTERIES; UTERINE ARTERY; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 85019927276     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dew357     Document Type: Article

References (49)

1. Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN, Bhansali A. Pregnancy outcome in hyperthyroidism: a case control study. Gynecol Obstet Invest 2014;77:94-99.
2. Aghajanova L, Stavreus-Evers A, Lindeberg M, Landgren BM, Sparre LS, Hovatta O. Thyroid-stimulating hormone receptor and thyroid hormone receptors are involved in human endometrial physiology. Fertil Steril 2011;95:230-237, 237. e1-2.
3. Barber KJ, Franklyn JA, McCabe CJ, Khanim FL, Bulmer JN, Whitley GS, Kilby MD. The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab 2005;90: 1655-1661.
4. Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol 2004;28:67-80.
5. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995:289-300.
6. Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of preeclampsia/ eclampsia and its adverse outcomes in low-and middleincome countries: a WHO secondary analysis. PLoS One 2014;9: e91198.
7. Boas M, Forman JL, Juul A, Feldt-Rasmussen U, Skakkebaek NE, Hilsted L, Chellakooty M, Larsen T, Larsen JF, Petersen JH et al. Narrow intraindividual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women. Eur J Endocrinol 2009;161:903-910.
8. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
9. Campbell S, Griffin DR, Pearce JM, Diaz-Recasens J, Cohen-Overbeek TE, Willson K, Teague MJ. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983;321:675-677.
10. Carter AM. Evolution of placental function in mammals: the molecular basis of gas and nutrient transfer, hormone secretion, and immune responses. Physiol Rev 2012;92:1543-1576.
11. Cartwright JE, Fraser R, Leslie K, Wallace AE, James JL. Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction 2010;140:803-813.
12. Crawford SL, Tennstedt SL, McKinlay JB. A comparison of anlaytic methods for non-random missingness of outcome data. J Clin Epidemiol 1995; 48:209-219.
13. Fowden AL, Forhead AJ, Sferruzzi-Perri AN, Burton GJ, Vaughan OR. Review: endocrine regulation of placental phenotype. Placenta 2015;36: S50-S59.
14. Friedman JH. Multivariate adaptive regression splines. Ann Stat 1991:1-67.
15. Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003;110:S99-S107.
16. Gaillard R, Arends LR, Steegers EA, Hofman A, Jaddoe VW. Second-and third-trimester placental hemodynamics and the risks of pregnancy complications: the generation R study. Am J Epidemiol 2013;177:743-754.
17. Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid 1999;9:631-635.
18. Guttmacher AE, Maddox YT, Spong CY. The Human Placenta Project: placental structure, development, and function in real time. Placenta 2014; 35:303-304.
19. Haddow JE, Craig WY, Neveux LM, Haddow HR, Palomaki GE, Lambert-Messerlian G, Malone FD, D'Alton ME, First, Second Trimester Risk of Aneuploidy Research C. Implications of high free thyroxine (FT4) concentrations in euthyroid pregnancies: the FaSTER trial. J Clin Endocrinol Metab 2014;99:2038-2044.
20. Imai K, Keele L, Yamamoto T. Identification, inference and sensitivity analysis for causal mediation effects. Stat Sci 2010:51-71.
21. Jaddoe VW, van Duijn CM, Franco OH, van der Heijden AJ, van Iizendoorn MH, de Jongste JC, van der Lugt A, Mackenbach JP, Moll HA, Raat H et al. The generation R study: design and cohort update 2012. Eur J Epidemiol 2012;27:739-756.
22. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Ross HA, Hooijkaas H, Tiemeier H et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 2013;98:4382-4390.
23. Korevaar TI, Steegers EA, de Rijke YB, Visser WE, Jaddoe VW, Visser TJ, Medici M, Peeters RP. Placental angiogenic factors are associated with maternal thyroid function and modify hCG-mediated FT4 stimulation. J Clin Endocrinol Metab 2015;100:E1328-E1334.
24. Korevaar TI, Muetzel R, Medici M, Chaker L, Jaddoe VW, de Rijke YB, Steegers EA, Visser TJ, White T, Tiemeier H et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol 2016;4:35-43.
25. Kovo M, Schreiber L, Ben-Haroush A, Asalee L, Seadia S, Golan A, Bar J. The placental factor in spontaneous preterm labor with and without premature rupture of membranes. J Perinat Med 2011;39:423-429.
26. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702-755.
27. Lash GE, Cartwright JE, Whitley GS, Trew AJ, Baker PN. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility. Placenta 1999;20:661-667.
28. Li H, Gudnason H, Olofsson P, Dubiel M, Gudmundsson S. Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one-third of late third-trimester preeclamptic women. Ultrasound Obstet Gynecol 2005;25:459-463.
29. Loubiere LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, Verrey F, McCabe CJ, Franklyn JA, Kilby MD, Chan SY. Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 2010;31:295-304.
30. Lyall F, Bulmer JN, Duffie E, Cousins F, Theriault A, Robson SC. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol 2001;158:1713-1721.
31. Matsuo H, Maruo T, Murata K, Mochizuki M. Human early placental trophoblasts produce an epidermal growth factor-like substance in synergy with thyroid hormone. Acta Endocrinol (Copenh) 1993;128:225-229.
32. Medici M, de Rijke YB, Peeters RP, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VV, Hofman A, Hooijkaas H, Steegers EA, Tiemeier H et al. Maternal early pregnancy and newborn thyroid hormone parameters: the generation R study. J Clin Endocrinol Metab 2012;97:646-652.
33. Medici M, Timmermans S, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VW, Hofman A, Hooijkaas H, de Rijke YB, Tiemeier H, Bongers-Schokking JJ et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the generation R study. J Clin Endocrinol Metab 2013;98:59-66.
34. Medici M, Korevaar TI, Schalekamp-Timmermans S, Gaillard R, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Hooijkaas H et al. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab 2014;99:E2591-E2598.
35. Mestman JH. Hyperthyroidism in pregnancy. Clin Obstet Gynecol 1997;40: 45-64.
36. Niklasson A, Albertsson-Wikland K. Continuous growth reference from 24th week of gestation to 24 months by gender. BMC Pediatr 2008;8:8.
37. Odibo AO, Patel KR, Spitalnik A, Odibo L, Huettner P. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol 2014;34:186-191.
38. Oki N, Matsuo H, Nakago S, Murakoshi H, Laoag-Fernandez JB, Maruo T. Effects of 3, 5, 3'-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab 2004;89: 5213-5221.
39. Otun HA, Lash GE, Innes BA, Bulmer JN, Naruse K, Hannon T, Searle RF, Robson SC. Effect of tumour necrosis factor in combination with interferon on first trimester extravillous trophoblast invasion. J Reprod Immunol 2011;88:1-11.
40. Patel J, Landers K, Li H, Mortimer RH, Richard K. Oxygen concentration regulates expression and uptake of transthyretin, a thyroxine binding protein, in JEG-3 choriocarcinoma cells. Placenta 2011;32:128-133.
41. Shambaugh G 3rd, Kubek M, Wilber JF. Thyrotropin-releasing hormone activity in the human placenta. J Clin Endocrinol Metab 1979;48:483-486.
42. Sheehan PM, Nankervis A, Araujo Junior E, Da Silva Costa F. Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab 2015;100:4325-4331.
43. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338:b2393.
44. Strimmer K. fdrtool: a versatile R package for estimating local and tail areabased false discovery rates. Bioinformatics 2008;24:1461-1462.
45. Vasilopoulou E, Loubiere LS, Lash GE, Ohizua O, McCabe CJ, Franklyn JA, Kilby MD, Chan SY. Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner. Hum Reprod 2014;29: 1161-1172.
46. Verburg BO, Jaddoe VW, Wladimiroff JW, Hofman A, Witteman JC, Steegers EA. Fetal hemodynamic adaptive changes related to intrauterine growth: the generation R study. Circulation 2008;117:649-659.
47. Vinnars MT, Papadogiannakis N, Nasiell J, Holmstrom G, Westgren M. Placental pathology in relation to stillbirth and neonatal outcome in an extremely preterm population: a prospective cohort study. Acta Obstet Gynecol Scand 2015;94:584-590.
48. Wulff C, Weigand M, Kreienberg R, Fraser HM. Angiogenesis during primate placentation in health and disease. Reproduction 2003;126: 569-577.
49. Youngblood WW, Humm J, Lipton MA, Kizer JS. Thyrotropin-releasing hormone-like bioactivity in placenta: evidence for the existence of substances other than Pyroglu-His-Pro-NH2 (TRH) capable of stimulating pituitary thyrotropin release. Endocrinology 1980;106:541-546.